Trial
NCT01288053
Non-myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (NST) for Patients With Refractory Crohn's Disease
Phase ITERMINATEDSAFETYConfidence: HIGH
Sponsor
Northwestern University
Collaborators
—
Condition
Crohn's Disease
Intervention
Allogeneic Stem Cell Therapy
Why stopped
No participant enrolled more than two years. No plan to continue study.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-08-06